Cargando…
Urinary Peptidomic Biomarker for Personalized Prevention and Treatment of Diastolic Left Ventricular Dysfunction
Diastolic heart failure (DHF) is characterized by slow left ventricular (LV) relaxation, increased LV stiffness, interstitial deposition of collagen, and a modified extracellular matrix proteins. Among Europeans, the frequency of asymptomatic diastolic LV dysfunction (DD) is 25%. This constitutes a...
Autores principales: | Zhang, Zhen‐Yu, Nkuipou‐Kenfack, Esther, Staessen, Jan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519355/ https://www.ncbi.nlm.nih.gov/pubmed/30632674 http://dx.doi.org/10.1002/prca.201800174 |
Ejemplares similares
-
Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction
por: Zhang, Zhen-Yu, et al.
Publicado: (2018) -
Urinary peptidomic biomarkers of renal function in heart transplant recipients
por: Huang, Qi-Fang, et al.
Publicado: (2019) -
Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure
por: Zhang, Zhen‐Yu, et al.
Publicado: (2017) -
Prognostic Value of Left Ventricular Diastolic Dysfunction in a General Population
por: Kuznetsova, Tatiana, et al.
Publicado: (2014) -
Apelin affects the mouse aging urinary peptidome with minimal effects on kidney
por: Vinel, Claire, et al.
Publicado: (2019)